{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T21:05:44Z","timestamp":1762981544713},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,1,3]]},"DOI":"10.1001\/jama.2022.23510","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T16:01:52Z","timestamp":1672761712000},"page":"14","source":"Crossref","is-referenced-by-count":2,"title":["First FDA-Approved Gene Therapy for Hemophilia"],"prefix":"10.1001","volume":"329","author":[{"given":"Howard","family":"Larkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2800046\/jama_larkin_2023_fd_220073_1671563430.10056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T16:01:54Z","timestamp":1672761714000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2800046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.23510","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}